From New Orleans, at the annual meeting of the Society for Neuroscience
Investigators are testing whether an antibiotic that manufacturers pulled from the U.S. market several decades ago for safety concerns can slow or prevent Alzheimer’s disease.
Many neuroscientists believe that a buildup in the brain of a protein fragment called beta-amyloid causes Alzheimer’s disease.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.